The Sunscreen Innovation Act (SIA) was enacted on November 26, 2014 to provide an alternative process for the review of safety and effectiveness of nonprescription sunscreen active ingredients.
The SIA supplements the FDA’s Time and Extent Application (TEA) regulation with new statutory procedures. The SIA also requires FDA to establish timeframes for review of TEAs for OTC drugs other than sunscreen active ingredients.
- FDA Voice Blog: FDA's Sunscreen Guidance outlines safety and effectiveness data needed for new active ingredients
- From our perspective: Helping to Ensure the safety and effectiveness of sunscreens